Abstract
BackgroundPatients suffering from systemic autoimmune rheumatic disease (SARD) display poor antibody development after two doses of mRNA vaccinations leaving these patients with only limited humoral protection against severe SARS-CoV-2 disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have